Nexalin Technology Inc. Insider Trading

NXL

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Mar 2025.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Mar 2025

Mar 12, 2025

Get an email when NXL's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Mar 12, 2025	Carolyn Hamby Shelton Sr. VP - Quality, Regulatory	Bought	6,000	$2.20	13K	25%	Form 4
Feb 4, 2025	David Owens Chief Medical Officer	Bought	1,000	$3.10	3K	0.6%	Form 4
Feb 4, 2025	David Owens Chief Medical Officer	Bought	1,000	$2.98	3K	0.7%	Form 4
Jan 28, 2025	David Owens Chief Medical Officer	Bought	1,500	$2.70	4K	1.0%	Form 4
Jan 13, 2025 – Jan 23, 2025	David Owens Chief Medical Officer	Bought 2 parts	3,000	$2.57 average	8K	2.0%	Form 4

Mar 12, 2025
Carolyn Hamby Shelton
Sr. VP - Quality, Regulatory · bought 6,000 at $2.20
13K
25% of stake
Feb 4, 2025
David Owens
Chief Medical Officer · bought 1,000 at $3.10
3K
0.6% of stake
Feb 4, 2025
David Owens
Chief Medical Officer · bought 1,000 at $2.98
3K
0.7% of stake
Jan 28, 2025
David Owens
Chief Medical Officer · bought 1,500 at $2.70
4K
1.0% of stake
Jan 13, 2025 – Jan 23, 2025
David Owens
Chief Medical Officer · bought 3,000 at avg $2.57
8K
2.0% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch NXL, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Electromedical & Electrotherapeutic Apparatus · Pick stocks to compare with NXL

CompareIntrinsic value

POSCPositron Corporation

$1.67-1.76%0

ENDVEndonovo Therapeutics Inc.

$0.00+0.00%15

GTHPGuided Therapeutics Inc.

$0.10-33.33%30

FOFAFamily Office of America Inc.

$0.78+0.00%16

COCHEnvoy Medical, Inc.

$7.50+13.22%10

RDGLVivos Inc.

$0.04-1.64%40

PAVMPAVmed Inc.

$1.66-8.79%25

LYRALyra Therapeutics Inc.

$0.19+0.00%0

Spot a number that looks wrong? Check it in NXL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing NXL

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.